How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Consultation

    Has all of the relevant evidence been taken into account?

  • Question on Consultation

    • Are the summaries of clinical and and cost effectiveness reasonable interpretations of the evidence?

  • Question on Consultation

    Are the recommendations sound and a suitable basis for guidance to the NHS?

  • Question on Consultation

    • Are there any equality issues that need special consideration and are not covered in the medical technology consultation document?
The content on this page is not current guidance and is only for the purposes of the consultation process.

myCOPD to self-manage chronic obstructive pulmonary disease

Closed for comments This consultation ended on at   Request commenting lead permission

1 Recommendations

1.1 myCOPD shows promise for self-managing chronic obstructive pulmonary disease (COPD). However there is not enough good-quality evidence to support the case for routine adoption.

1.2 Further comparative research is recommended to address uncertainties about myCOPD's clinical benefits on outcomes such as the rate of acute exacerbation and how it affects healthcare resource use such as hospital admissions.

Find out more in the section on further research.

Why the committee made these recommendations

Most people with COPD manage their condition at home. myCOPD is an app that helps people with COPD understand the condition and manage their symptoms. myCOPD provides access to online education, self-management advice, symptom reporting and pulmonary rehabilitation. People using the app can share their clinical information with healthcare professionals, to help make shared decisions about treatment.

The evidence suggests that using myCOPD could have clinical benefits compared with standard care. But this is uncertain because the trials were short and included few people.

The cost savings are uncertain, because of the uncertainty about the clinical evidence and how much myCOPD affects healthcare resource use. More evidence is needed to resolve these uncertainties, so further research is recommended.